FDA guidance
Bisacodyl; Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium…
FDA guidance · Draft · issued May 16, 2017
Key facts
| Title | Bisacodyl; Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride (For Solution, Tablet, Delayed Release - Oral) |
|---|---|
| Status | Draft |
| Issue date | May 16, 2017 |
| Center | Center for Drug Evaluation and Research |
| Regulated product | Drugs |
| Topics | Product-Specific Guidance |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents